Funding and Valuation - Finnish health tech company Oura has raised $900 million in funding led by Fidelity Management & Research Company, valuing the company at approximately $11 billion, more than double its last round valuation in December [1][2] - The funding round included participation from new investor ICONIQ and contributions from Whale Rock and Atreides [1] Business Growth and Revenue - Oura has sold over 5.5 million smart rings since its launch, with more than half of those sales occurring in the past year [4] - The company reported more than doubled revenue in 2024, reaching $500 million, and expects sales to cross $1 billion this year [4] Product Development and Market Strategy - The new funding will be used for AI and production innovation, introducing new health features, and improving global distribution [3] - Oura is expanding its customer base, with women in their early twenties becoming a core market [5] - The company launched its latest device, Oura ring 4, last October, along with ceramic versions and a new optional charging dock [5] New Features and Competition - Oura has introduced a new feature called Health Panels, allowing users to book a blood test for $99 at Quest Diagnostics labs across the U.S. [6] - This new blood testing feature positions Oura against competitors like Whoop, Ultrahuman, and Samsung [7]